Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 13, Issue 11, Pages 659-673
Publisher
Springer Nature
Online
2016-05-17
DOI
10.1038/nrclinonc.2016.64
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Daily oral topotecan: Utilization of a metronomic dosing schedule to treat recurrent or persistent solid tumors
- (2017) T. D. Tillmanns et al. JOURNAL OF CLINICAL ONCOLOGY
- Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development
- (2016) Marina E Cazzaniga et al. Future Oncology
- Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenografts
- (2015) Joshua C Doloff et al. BMC CANCER
- Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours
- (2015) B Milojkovic Kerklaan et al. BRITISH JOURNAL OF CANCER
- Mécanismes des interactions pharmacocinétiques impliquant les agents anticancéreux oraux
- (2015) Dominique Levêque et al. BULLETIN DU CANCER
- Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model
- (2015) Maria Tagliamonte et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Integrated PK-PD and agent-based modeling in oncology
- (2015) Zhihui Wang et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- When less is more: maintenance therapy in colorectal cancer
- (2015) Joleen M Hubbard et al. LANCET
- Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group
- (2015) Lieke H J Simkens et al. LANCET
- Rationale for metronomic chemotherapy in phase III trials
- (2015) Robert S. Kerbel et al. Nature Reviews Clinical Oncology
- Clinical overview of metronomic chemotherapy in breast cancer
- (2015) Elisabetta Munzone et al. Nature Reviews Clinical Oncology
- Computational oncology — mathematical modelling of drug regimens for precision medicine
- (2015) Dominique Barbolosi et al. Nature Reviews Clinical Oncology
- A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck
- (2015) Vijay Maruti Patil et al. ORAL ONCOLOGY
- Postsurgical adjuvant or metastatic renal cell carcinoma therapy models reveal potent antitumor activity of metronomic oral topotecan with pazopanib
- (2015) Christopher Jedeszko et al. Science Translational Medicine
- Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine
- (2015) Sébastien Benzekry et al. SEMINARS IN CANCER BIOLOGY
- Germline oncopharmacogenetics, a promising field in cancer therapy
- (2015) Chiara Pesenti et al. CELLULAR ONCOLOGY
- Metronomic cyclophosphamide eradicates large implanted GL261 gliomas by activating antitumor Cd8+T-cell responses and immune memory
- (2015) Junjie Wu et al. OncoImmunology
- Intermittent Metronomic Drug Schedule Is Essential for Activating Antitumor Innate Immunity and Tumor Xenograft Regression
- (2015) Chong-Sheng Chen et al. NEOPLASIA
- Optimizing drug therapy in pediatric SCT: Focus on pharmacokinetics
- (2014) J S McCune et al. BONE MARROW TRANSPLANTATION
- Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer
- (2014) L Bazzola et al. BRITISH JOURNAL OF CANCER
- Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients
- (2014) Lisa Derosa et al. CANCER
- Postsurgical Adjuvant Tumor Therapy by Combining Anti-Angiopoietin-2 and Metronomic Chemotherapy Limits Metastatic Growth
- (2014) Kshitij Srivastava et al. CANCER CELL
- Metronomics chemotherapy: time for computational decision support
- (2014) Dominique Barbolosi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- New insights into metronomic chemotherapy-induced immunoregulation
- (2014) Yi-Bin Hao et al. CANCER LETTERS
- Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma model
- (2014) Junjie Wu et al. CANCER LETTERS
- Optimizing Dosing of Oncology Drugs
- (2014) L Minasian et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Review of therapeutic drug monitoring of anticancer drugs part two – Targeted therapies
- (2014) Nicolas Widmer et al. EUROPEAN JOURNAL OF CANCER
- Review of therapeutic drug monitoring of anticancer drugs part 1 – Cytotoxics
- (2014) Angelo Paci et al. EUROPEAN JOURNAL OF CANCER
- Drug interactions with phytotherapeutics in oncology
- (2014) Walter Emil Haefeli et al. Expert Opinion on Drug Metabolism & Toxicology
- Combination of interleukin-12 gene therapy, metronomic cyclophosphamide and DNA cancer vaccination directs all arms of the immune system towards tumor eradication
- (2014) Sofie Denies et al. JOURNAL OF CONTROLLED RELEASE
- Anti-tumor innate immunity activated by intermittent metronomic cyclophosphamide treatment of 9L brain tumor xenografts is preserved by anti-angiogenic drugs that spare VEGF receptor 2
- (2014) Joshua C Doloff et al. Molecular Cancer
- Metronomics: towards personalized chemotherapy?
- (2014) Nicolas André et al. Nature Reviews Clinical Oncology
- Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response
- (2014) Genevieve M Weir et al. OncoImmunology
- Metronomics as Maintenance Treatment in Oncology: Time for Chemo-Switch
- (2014) Prabhat Singh Malik et al. Frontiers in Oncology
- The pharmacological bases of the antiangiogenic activity of paclitaxel
- (2013) Guido Bocci et al. ANGIOGENESIS
- Pharmacokinetics
- (2013) Jianghong Fan et al. BIOCHEMICAL PHARMACOLOGY
- Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study
- (2013) Evangelos Briasoulis et al. BMC CANCER
- A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours
- (2013) A Adenis et al. BRITISH JOURNAL OF CANCER
- A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens
- (2013) C. Faivre et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Clinical Implementation of Germ Line Cancer Pharmacogenetic Variants During the Next-Generation Sequencing Era
- (2013) N K Gillis et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Is a nurse-led telephone intervention a viable alternative to nurse-led home care and standard care for patients receiving oral capecitabine? Results from a large prospective audit in patients with colorectal cancer
- (2013) Olive Craven et al. EUROPEAN JOURNAL OF CANCER CARE
- Preclinical analysis of resistance and cross-resistance to low-dose metronomic chemotherapy
- (2013) Annabelle Chow et al. INVESTIGATIONAL NEW DRUGS
- A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group
- (2013) Emmanouil Kontopodis et al. JOURNAL OF CHEMOTHERAPY
- Has the time come for metronomics in low-income and middle-income countries?
- (2013) Nicolas André et al. LANCET ONCOLOGY
- Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers
- (2012) Giacomo Allegrini et al. ANGIOGENESIS
- Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel
- (2012) Li-Min Luo et al. BIOMATERIALS
- Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab
- (2012) Silvia Dellapasqua et al. BREAST
- Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases
- (2012) Raffaele Addeo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Thrombospondin-1 and pigment epithelium-derived factor enhance responsiveness of KM12 colon tumor to metronomic cyclophosphamide but have disparate effects on tumor metastasis
- (2012) Li Jia et al. CANCER LETTERS
- VEGF Receptor Inhibitors Block the Ability of Metronomically Dosed Cyclophosphamide to Activate Innate Immunity-Induced Tumor Regression
- (2012) J. C. Doloff et al. CANCER RESEARCH
- Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma
- (2012) S. J. Lee et al. CLINICAL CANCER RESEARCH
- The efficacy of temozolomide for recurrent glioblastoma multiforme
- (2012) Chao Chen et al. EUROPEAN JOURNAL OF NEUROLOGY
- Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel
- (2012) Johannes Moes et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy
- (2012) Mariana S. Nars et al. INTERNATIONAL JOURNAL OF CANCER
- Concise Drug Review: Pazopanib and Axitinib
- (2012) R. M. J. M. van Geel et al. ONCOLOGIST
- Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome
- (2011) Yingzi Ge et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Metronomic Oral Topotecan with Pazopanib Is an Active Antiangiogenic Regimen in Mouse Models of Aggressive Pediatric Solid Tumor
- (2011) S. Kumar et al. CLINICAL CANCER RESEARCH
- Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?
- (2011) Nicolas Penel et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Therapeutic drug monitoring and LC–MS/MS
- (2011) Joanne E. Adaway et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- A Phase II Randomized Trial of Gefitinib Alone or with Tegafur/Uracil Treatment in Patients with Pulmonary Adenocarcinoma Who had Failed Previous Chemotherapy
- (2011) Yuh-Min Chen et al. Journal of Thoracic Oncology
- Microassay of drugs and modern measurement techniques
- (2011) Jeff S. Millership PEDIATRIC ANESTHESIA
- Antiangiogenic Activity of Sterically Stabilized Liposomes Containing Paclitaxel (SSL-PTX): In Vitro and In Vivo
- (2010) Yue Huang et al. AAPS PHARMSCITECH
- Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care
- (2010) N Penel et al. BRITISH JOURNAL OF CANCER
- Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma
- (2010) William M. Merritt et al. CANCER BIOLOGY & THERAPY
- Low-Dose Metronomic Oral Administration of Vinorelbine in the First-line Treatment of Elderly Patients With Metastatic Breast Cancer
- (2010) Raffaele Addeo et al. Clinical Breast Cancer
- Metronomic chemotherapy: Back to the future!
- (2010) N. André et al. DRUG NEWS & PERSPECTIVES
- Potent Preclinical Impact of Metronomic Low-Dose Oral Topotecan Combined with the Antiangiogenic Drug Pazopanib for the Treatment of Ovarian Cancer
- (2010) Kae Hashimoto et al. MOLECULAR CANCER THERAPEUTICS
- Metronomic Chemotherapy Enhances Antitumor Effects of Cancer Vaccine by Depleting Regulatory T Lymphocytes and Inhibiting Tumor Angiogenesis
- (2010) Chi-An Chen et al. MOLECULAR THERAPY
- A phase II study of metronomic oral topotecan for recurrent childhood brain tumors
- (2010) Jane E. Minturn et al. PEDIATRIC BLOOD & CANCER
- Temozolomide in malignant gliomas: current use and future targets
- (2009) J. Lee Villano et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
- (2009) Claire Banissi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Antivascular Actions of Microtubule-Binding Drugs
- (2009) E. L. Schwartz CLINICAL CANCER RESEARCH
- Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer
- (2009) E. Briasoulis et al. CLINICAL CANCER RESEARCH
- Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab
- (2009) A. Calleri et al. CLINICAL CANCER RESEARCH
- Functionalized nanospheres loaded with anti-angiogenic drugs: Cellular uptake and angiosuppressive efficacy
- (2009) Taha Hammady et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer
- (2009) Anna Fioravanti et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Role of UFT in Metastatic Colorectal Cancer
- (2009) Jaafar Bennouna et al. ONCOLOGY
- A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients
- (2008) G Allegrini et al. BRITISH JOURNAL OF CANCER
- Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib
- (2008) G Bocci et al. BRITISH JOURNAL OF CANCER
- Evaluation of antiproliferative and molecular effects of vinorelbine and its active metabolite 4-O-deacetyl-vinorelbine on human endothelial cells in an in vitro simulation model of metronomic chemotherapy
- (2008) P. Pappas et al. EJC SUPPLEMENTS
- Drug testing: Figure 1
- (2008) David A. Cowan Essays in Biochemistry
- Dose calculation of anticancer drugs
- (2008) Bo Gao et al. Expert Opinion on Drug Metabolism & Toxicology
- Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast Cancer
- (2008) Silvia Dellapasqua et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacokinetic-directed dosing of vandetanib and docetaxel in a mouse model of human squamous cell carcinoma
- (2008) E. L. Bradshaw-Pierce et al. MOLECULAR CANCER THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started